Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …

Purpose Statins have potential protective effects against cancers, but no studies have
focused on patients with chronic hepatitis B virus (HBV) infection. The purpose of this study …

Background & Aims The use of statin in hepatocellular carcinoma (HCC) and death
prevention is still uncertain among hepatitis B infected (HBV) patients. This study aimed to …

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer-
related mortality worldwide. Several studies have shown that statins could have …

Importance Given the burden of chronic liver disease on the health care system, more
information on the hepatoprotective association of statins in the general population is …

Background & Aims Statins are widely used to treat hypercholesterolemia. Statins may
prevent hepatocellular carcinoma (HCC), but have not yet been fully studied, particularly in …

Purpose Statins may have protective effects against cancer, but no studies have focused on
their effects in patients with chronic hepatitis C virus (HCV) infection. The purpose of this …

Statins can decrease hepatocellular carcinoma (HCC) occurrence, but the magnitude and
the predictors of these effects remain unclear. This meta-analysis provides a pooled …

Background. The use of statins is a potential protective factor against the development of
hepatocellular carcinoma. Therefore, we conducted a meta‐analysis to evaluate the …

Background and Aims: Statins are the first-line medication to treating hypercholesterolemia.
Several studies have investigated the impact of statins on the risk of hepatocellular …